Intrinsiqq
Zyversa Therapeutics Inc. logo

Zyversa Therapeutics Inc. Financials

ZVSA

Compare

All currency values in $ millions unless otherwise noted

Scroll

Income Statement
DEC 2025
~5.4:1 split
DEC 2024
~11.4:1 split
DEC 2023
~3.8:1 split
DEC 2022
DEC 2021
General & Administrative$6$7$11––
Research & Development$1$2$3––
Total Operating Expenses$25$9$108––
Operating Income-$25-$9-$108––
EBT (Earnings Before Tax)-$26-$9-$108––
Income Tax Expense-$1$0-$9––
Net Income
Net Income-$25-$9-$98––
EPS (Basic)-$4.18-$8.48-$1,089.70––
EPS (Diluted)-$4.18-$8.48-$1,089.70––
Weighted Avg Shares (Basic)6.0M1.1M975,0359.0M–
Weighted Avg Shares (Diluted)6.0M1.1M975,035257,604–
Shares Outstanding6.0M1.1M97,503.525,760.4–

Zyversa Therapeutics (ZVSA) financials: revenue, profit and margins

Zyversa Therapeutics (ZVSA) generated about n/a in revenue and -$24 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Zyversa Therapeutics profitable?+

Zyversa Therapeutics reported about -$24 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 11 May 2026, covering the period ending 31 Mar 2026, as reported to the SEC. Data last refreshed 8 Oct 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ZVSA

CompareIntrinsic value
ANABAnaptysBio Inc.
$46.63-1.62%20
KZRKezar Life Sciences, Inc.
No recent price20
SCNXScienture Holdings Inc.
$2.28-6.45%0
UNCYUnicycive Therapeutics Inc.
$3.35-5.10%10
XOMAXOMA Corporation
€0.04-3.86%64
FBIOFortress Biotech Inc.
$1.90+7.34%59
ANIPAni Pharmaceuticals Inc.
$68.55-0.84%85
GTBPGT Biopharma, Inc.
$2.96-6.92%20

Spot a number that looks wrong? Check it in ZVSA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ZVSA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.